India Surgical Robotics Market By Application (Orthopedics, Neurology, Urology, Gynecology, Others), By End Use (Inpatient, Outpatient), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

The India Surgical Robotics Market was valued at USD 24.72 million in 2024 and is expected to reach USD 44.91 million by 2030, with a CAGR of 10.42% during the forecast period.

The India Surgical Robotics Market is experiencing rapid expansion, driven by increasing demand for minimally invasive surgeries (MIS), technological advancements, and growing healthcare infrastructure investments. The rising prevalence of chronic diseases such as cancer, neurological disorders, and orthopedic conditions has further fueled the adoption of robotic-assisted procedures, particularly in orthopedics, urology, neurology, and gynecology. 

Leading hospitals, including Apollo, Fortis, and AIIMS, are actively integrating surgical robots to enhance precision, reduce post-operative complications, and improve patient outcomes. Medical tourism is a significant contributor, with India emerging as a preferred destination for cost-effective yet advanced robotic surgeries.

Despite the promising growth, the market faces several challenges, including high initial costs, a shortage of skilled robotic surgeons, and limited penetration in tier 2 and tier 3 cities. The cost of robotic surgical systems, such as the Da Vinci (Intuitive Surgical) and Mako (Stryker) systems, remains a significant barrier for mid-sized hospitals. 

Training requirements for surgeons and regulatory approvals slow down widespread adoption. However, government initiatives promoting "Make in India" and increased private-sector investments in robotic-assisted surgery centers are expected to bridge these gaps. As more domestic manufacturers and startups enter the market, the affordability and accessibility of surgical robotics are expected to improve, positioning India as a key player in the global landscape.

Key Market Drivers

Increasing Healthcare Infrastructure

India’s expanding healthcare infrastructure is accelerating adoption of surgical robotics, especially in tertiary and specialty hospitals. As of March 31, 2023, India had 1,69,615 Sub-Centres, 31,882 PHCs, 6,359 CHCs, 1,340 SDHs, 714 District Hospitals, and 362 Medical Colleges, providing the base for advanced surgical care amid rising chronic diseases, surgical volumes, and demand for minimally invasive procedures.

Workforce growth further supports robotic integration, with 2,39,911 health workers at Sub-Centres, 40,583 doctors at PHCs, 26,280 specialists/medical officers at CHCs, 45,027 doctors and specialists at SDHs/DHs, plus 47,932 staff nurses at PHCs, 51,059 nursing staff at CHCs, and 1,35,793 paramedical staff at SDHs/DHs, strengthening perioperative readiness and postoperative care.

Infrastructure is also expanding, with 8,18,661 hospital beds across PHCs, CHCs, SDHs, DHs, and medical colleges (Health Dynamics of India 2022–23), supporting robotic procedures in orthopedics, urology, neurology, and gynecology. Private players such as Apollo, Fortis, Manipal, and Max Healthcare are actively investing in robotic systems, while Ayushman Bharat offers cashless coverage of up to Rs. 5 lakh per family per year to about 10.74 crore vulnerable families, improving access to advanced surgical care and reinforcing infrastructure-led growth of India’s surgical robotics market.

Growing Prevalence of Chronic Diseases

India’s rising chronic disease burden is driving demand for robotic-assisted surgeries across orthopedics, cardiology, urology, and oncology. According to the Government of India’s LASI Wave 1, among adults aged 60+, 32% report hypertension, 14.2% diabetes/high blood sugar, 2.7% stroke, and 8.3% chronic lung disease conditions that often require complex interventions such as coronary revascularization, valve repairs, limb-salvage, and thoracic procedures.

Cardiovascular risk remains significant in older populations, with 32% hypertension and 2.7% stroke, supporting growing volumes of heart surgeries where robotic precision improves outcomes. Bone and joint disorders like osteoarthritis and rheumatoid arthritis are also increasing robotic orthopedic procedures, while chronic lung disease is boosting demand for robotic thoracic surgery.

Globally, the WHO reports 43 million NCD deaths in 2021, accounting for 75% of non-pandemic-related deaths, with 73% occurring in low- and middle-income countries, highlighting mounting pressure on healthcare systems like India’s.

Robotic-assisted surgery improves accuracy, shortens recovery, and lowers post-operative risks. As NCD prevalence continues to rise, surgical robotics is set to play a larger role in delivering high-precision, minimally invasive care across India’s leading hospitals and specialty centers.

Technological Advancements in Robotic Surgery

Rapid advancements in robotic surgical technologies are significantly driving their adoption in India. The latest systems offer enhanced 3D visualization, improved haptic feedback, and higher precision, enabling surgeons to perform complex procedures with greater accuracy and control. For instance, government-reported tertiary care capacity such as 362 medical colleges and 714 district hospitals as of March 31, 2023 strengthens the institutional base where advanced robotic platforms are typically deployed and scaled.

The integration of artificial intelligence and machine learning in robotic platforms is enhancing decision-making during surgeries, reducing errors, and shortening operation times. For instance, the Union Cabinet-approved IndiaAI Mission has a budget outlay of Rs 10,371.92 crore and includes plans for AI compute infrastructure of 10,000 or more GPUs, helping expand the broader ecosystem that can enable AI-enabled surgical innovation and clinical deployment in India.

Additionally, the development of cost-effective robotic systems tailored for emerging markets, such as India, is making these technologies more affordable for hospitals. Training programs and simulation-based learning modules are also enhancing surgeon proficiency, which in turn is accelerating the adoption of robotic-assisted surgeries across multiple specialties. For instance, government health workforce reporting shows 45,027 doctors and specialists in sub-divisional and district hospitals, supported by 1,35,793 paramedical staff, creating a deeper operational talent pool that can be upskilled for robotic operating room workflows as adoption expands.

Download Free Sample Report

Key Market Challenges

High Cost of Surgical Robotics

One of the biggest challenges in the India Surgical Robotics Market is the high cost associated with robotic surgical systems, maintenance, and procedural expenses. 

Advanced robotic platforms, such as the Da Vinci (Intuitive Surgical), Mako (Stryker), and Rosa (Zimmer Biomet), require significant capital investment, often making them unaffordable for small and mid-sized hospitals, particularly in tier 2 and tier 3 cities. The cost of a single robotic surgical system ranges between INR 10-20 crore ($1.2-$2.4 million), with additional expenses for training surgeons, software updates, and annual maintenance contracts (AMCs), further increasing the financial burden on healthcare providers.

Beyond the initial purchase, robotic-assisted surgeries are generally more expensive than conventional procedures due to the cost of consumables, robotic instruments, and extended operating times. For example, a robotic-assisted knee replacement may cost anywhere between INR 3-5 lakh ($3,600-$6,000) per procedure, nearly double the cost of traditional surgery. This pricing disparity limits accessibility for a large section of India's population, particularly in rural and semi-urban areas, where affordability remains a critical concern.

Additionally, insurance coverage for robotic surgeries remains limited, with many policies considering them an "elective procedure" rather than a necessary one. This lack of financial support from insurers discourages patients from opting for robotic-assisted procedures, further restricting market penetration. While private hospitals in metro cities like Delhi, Mumbai, Bangalore, and Chennai are investing heavily in robotic surgery, government hospitals and mid-tier medical institutions struggle to justify the expenditure due to budget constraints and the need to cater to a larger patient base with cost-effective treatments.

Key Market Trends

Technological Advancements in Robotics

Rapid advancements in robotic surgical technologies are significantly driving their adoption in India. The latest systems offer enhanced 3D visualization, improved haptic feedback, and higher precision, enabling surgeons to perform complex procedures with greater accuracy and control. For instance, Health Dynamics of India reports that as of March 31, 2023, India had 714 district hospitals and 362 medical colleges, which are among the primary settings where advanced operating rooms and robotic programs are typically established and scaled.

The integration of artificial intelligence and machine learning in robotic platforms is enhancing decision-making during surgeries, reducing errors, and shortening operation times. For instance, the Union Cabinet approved the IndiaAI Mission with a budget outlay of Rs 10,371.92 crore and a plan to build AI compute infrastructure of 10,000 or more GPUs, strengthening the national foundation for applied AI development that can translate into clinical and surgical technology innovation.

Additionally, the development of cost-effective robotic systems tailored for emerging markets, such as India, is making these technologies more affordable for hospitals. Training programs and simulation-based learning modules are also enhancing surgeon proficiency, which in turn is accelerating the adoption of robotic-assisted surgeries across multiple specialties; for instance, Health Dynamics of India reports 45,027 doctors and specialists at sub-divisional and district hospitals, supported by 1,35,793 paramedical staff, indicating a sizeable workforce base that can be upskilled into robotic operating room workflows.

Another game-changer is the integration of 5G connectivity and remote surgery capabilities. With ultra-low latency, telerobotic surgery allows expert surgeons from metro cities to operate on patients in remote locations, addressing India’s disparity in specialized healthcare access; for instance, the Department of Telecommunications Year End Review states that 5G is available in 99.9 percent of districts with 85 percent population coverage and that 5.08 lakh 5G base transceiver stations were installed as of October 31, 2025, while also noting that 100 5G use case labs were awarded and operationalized since April 2025.

Growing Focus on Cost-Effective Robotic Solutions

An emerging trend in India’s surgical robotics market is the push toward affordable robotic platforms, as high acquisition and maintenance costs have been a barrier to adoption, particularly for mid-sized hospitals. For instance, government-reported infrastructure shows a broad base of potential mid-tier adopters, including 1,340 sub-divisional or district hospitals and 714 district hospitals, alongside 362 medical colleges as of March 31, 2023, where leasing and pay-per-use models can help spread costs across higher procedure volumes without heavy upfront capital expenditure.

To address affordability constraints, domestic manufacturers and global players are increasingly exploring competitively priced systems and flexible commercial models, and this direction aligns with wider Government of India efforts to reduce medtech costs through domestic manufacturing and common infrastructure, such as the PLI-linked push for high-end devices where domestically manufactured products are stated to be about 10 percent to 30 percent cheaper than imported products and the development of medical device parks with shared facilities that lower per-unit manufacturing and validation costs. This enables wider adoption in Tier 2 and Tier 3 cities, helping hospitals deliver advanced surgical care while improving operating and capital efficiency, and as competition intensifies, pricing pressure is expected to improve affordability further and expand access to robotic-assisted surgeries for a broader patient base.

Segmental Insights

End Use Insights

Based on End Use, Inpatient has emerged as the dominating segment in the India Surgical Robotics Market in 2024. This is primarily due to the complex nature of robotic-assisted surgeries, the need for post-operative monitoring, and the high cost associated with these procedures. Most robotic surgeries, such as orthopedic joint replacements, urological procedures (including prostatectomies), gynecological surgeries (including hysterectomies), and neurosurgical procedures, are performed in multispecialty hospitals and tertiary care centers, where patients often require extended recovery periods and specialized post-operative care.

Additionally, the high infrastructure requirements for robotic-assisted surgeries, including dedicated surgical suites, trained personnel, and advanced robotic systems, make inpatient hospitals the primary adopters of these technologies. Leading hospitals in metropolitan cities, such as Apollo Hospitals, AIIMS, Max Healthcare, and Fortis Healthcare, have heavily invested in surgical robotics, reinforcing the dominance of the inpatient segment.

Download Free Sample Report

Regional Insights

Based on Region, South India has emerged as the dominating region in the India Surgical Robotics Market in 2024. It is driven by its well-established healthcare infrastructure, high concentration of multispecialty hospitals, and faster adoption of advanced medical technologies. Cities such as Chennai, Bengaluru, Hyderabad, and Kochi have become key hubs for robotic-assisted surgeries, with hospitals investing heavily in state-of-the-art robotic surgical systems to enhance precision and patient outcomes.

Tamil Nadu and Karnataka lead the adoption of surgical robotics, with premier hospitals such as Apollo Hospitals, Narayana Health, Manipal Hospitals, and Fortis Healthcare pioneering the use of robotic-assisted procedures in orthopedics, urology, gynecology, and neurology. Bengaluru, often referred to as the "Silicon Valley of India," has also seen a rise in medical technology startups and research initiatives focused on robotic surgery, further fueling regional growth.

Additionally, South India's strong medical tourism sector plays a crucial role in market dominance. Cities like Chennai and Hyderabad attract a large number of international and domestic patients seeking robotic-assisted surgeries for knee replacements, prostate cancer, and minimally invasive procedures. The presence of renowned medical institutions and government support for advanced healthcare technologies has further solidified South India's position as the top-performing region in India's surgical robotics market.

Recent Development

• In January 2026, SS Innovations announced development of five 5mm robotic instruments (e.g., needle driver, bipolar forceps, grasping forceps) to broaden its instrument set for smaller-anatomy procedures such as pediatric applications.
• In December 2025, CK Birla Hospital announced a collaboration (MoU) with Intuitive India to introduce the fourth-generation da Vinci surgical robot and associated training/support.
• In September 2025, Meril unveiled Mizzo Endo 4000, a next-generation soft-tissue surgical robotic system featuring AI-enabled imaging/3D mapping, as well as 5G-enabled telesurgery capabilities.
• In January 2025, a hospital in Pune introduced its first Made-in-India surgical robot, SSI Mantra, developed by SS Innovations. This advanced robotic system enhances minimally invasive procedures, offering greater precision and faster recovery. The installation marks a significant step in India’s adoption of surgical robotics, making high-tech, robotic-assisted surgeries more accessible and cost-effective for patients in the region.
• In January 2025, Prashanth Hospitals launched the Institute of Robotic Surgery, introducing a cutting-edge surgical robotic system for minimally invasive procedures. This initiative aims to enhance precision, reduce recovery time, and improve patient outcomes across specialties like urology, gynecology, and oncology. The hospital's investment underscores its commitment to advancing robotic-assisted surgery in India's healthcare sector.
• In January 2025, Maharashtra received its first Made-in-India surgical robot, SSI Mantra, developed by SS Innovations. This milestone marks a significant advancement in robotic-assisted surgery, enhancing precision and efficiency in minimally invasive procedures. Installed in a leading hospital, the system aims to make cutting-edge surgical technology more accessible and affordable for patients across the state.

Key Market Players

• Smith & Nephew Healthcare Pvt Ltd
• Intuitive Surgical, Inc.
• Renishaw Metrology Systems Ltd.
• Medtronic plc
• Stryker Corporation
• Zimmer Biomet India
• SS Innovations International Inc.

Report Scope

In this report, the India Surgical Robotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Surgical Robotics Market, By Application:

o   Orthopedics

o   Neurology

o   Urology

o   Gynecology

o   Others

• India Surgical Robotics Market, By End Use:

o   Inpatient

o   Outpatient

• India Surgical Robotics Market, By Region:

o   East India

o   West India

o   North India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Surgical Robotics Market.

Available Customizations:

India Surgical Robotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Surgical Robotics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]